Table 3.
The relationship between the levels of sB7-H5 in sera of patients with LC and clinicopathological characteristics.
| Characteristics | N | sB7-H5 expression | U | P | |
|---|---|---|---|---|---|
| Median (Min–Max) | P 25 ~P75 | ||||
| Age | |||||
| ≤67 | 62 | 389.2 (134.7-925.2) | 338.2-453.6 | 1588 | 0.1646 |
| >67 | 60 | 415.0 (213.8-1655) | 360.5-527.9 | ||
| Gender | |||||
| Male | 75 | 403.3 (216.2-1191) | 359.8-470.2 | 1728 | 0.8576 |
| Female | 47 | 409.1 (134.7-1655) | 327.0-492.5 | ||
| TNM | |||||
| I+II | 32 | 388.4 (140.6-501.5) | 273.1-453.7 | 1089 | 0.0405∗ |
| III+IV | 90 | 409.0 (134.7-1655) | 360.3-505.0 | ||
| Metastasis | |||||
| No | 22 | 325.6 (140.6-501.5) | 247.9-428.7 | 629.5 | 0.0014∗∗ |
| Yes | 100 | 413.0 (134.7-1655) | 360.5-486.7 | ||
TNM: tumor node metastasis. ∗P < 0.05; ∗∗P < 0.01.